ImmunityBio Inc Ordinary Shares IBRX 深 沪
等待开盘 08-11 09:30:00 美东时间
7.49
-0.150
-1.96%
华盛通- 最 高7.70
- 今 开7.51
- 成交量 583.73万股
- 最 低 6.70
- 昨 收 7.64
- 总市值 298.10万
- 52周最高 12.43
- 市盈率 静 --
- 换手率 1466.66%
- 52周最低 1.95
- 委 比 -97.05%
- 总股本 0.00亿
- 历史最高 45.42
- 量 比 0.47
- 振 幅 13.09%
- 历史最低 0.93
- 每 手 1
- 风险率 2.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Squeeze Watch: 10 Stocks Bears Love to Hate Most Right Now
Lucid, Figma, SoundHound and Ondas are among the most heavily shorted stocks in the market right now.
07-14 02:29
Jim Cramer Calls CAVA 'Tasty, Clean, Fun,' Says Make This Biotech 'Your Speculation'
Jim Cramer recommended buying CAVA Group (CAVA), citing its potential and tasty, clean, and fun concept, also likes Trulieve Cannabis (TRLV) and advised holding onto Ashland (ASH).
06-17 19:50
ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership
ImmunityBio secures exclusive U.S. rights to Japan BCG Lab's Tokyo strain of BCG, aiming to end a decade-long U.S. supply shortage.
05-18 22:20
FDA Flags Anktiva Claims While ImmunityBio Pushes Regulatory Fixes
ImmunityBio responds to FDA warning on Anktiva promotions, while NCCN update and rising sales support growth narrative.
04-06 23:14
ImmunityBio Submits FDA Response On Ad, Podcast Issues; Co. Tells FDA TV Ad Never Aired, Responds On Podcast
Company initiated a comprehensive review of promotional materials and is implementing enhanced advertising compliance measures, including expanded promotional review protocols, executive training, and external regulatory
04-06 19:37
Why Are ImmunityBio Shares Rising Today?
Shares of ImmunityBio, Inc. (NASDAQ: IBRX) are lifting after the company announced it secured $75 million in non-dilutive financing.
04-01 00:48
FDA Issues Warning To ImmunityBio Over Misleading Anktiva Promotions, Says False & Misleading Claims/Misbranded
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/immunitybio-inc-725468-03132026
03-24 21:37
Lucid Tops The Most-Shorted Stock List—Here Are 9 More Short Targets
Lucid, CleanSpark and Hims & Hers are the top 3 most shorted stocks. Here's the rest of the top ten.
03-12 03:20
ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug
ImmunityBio resubmits the ANKTIVA application to the FDA after a prior setback.
03-09 23:03
ImmunityBio Investors Rally Behind Cancer Trial Milestone
ImmunityBio stock rises after 85% response rate in bladder cancer study, topping BCG alone; FDA filing planned for 2026.
02-26 21:57
